Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck.
about
Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerAn Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma.Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis.Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.
P2860
Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immunological modulation by 1α ...... arcinoma of the head and neck.
@ast
Immunological modulation by 1α ...... arcinoma of the head and neck.
@en
type
label
Immunological modulation by 1α ...... arcinoma of the head and neck.
@ast
Immunological modulation by 1α ...... arcinoma of the head and neck.
@en
prefLabel
Immunological modulation by 1α ...... arcinoma of the head and neck.
@ast
Immunological modulation by 1α ...... arcinoma of the head and neck.
@en
P2093
P2860
P1433
P1476
Immunological modulation by 1α ...... arcinoma of the head and neck.
@en
P2093
Anna-Maria de Costa
Corinne Schuyler
David D Walker
M Rita I Young
Travis D Reeves
P2860
P304
P356
10.1016/J.CYTO.2012.03.002
P577
2012-03-24T00:00:00Z